The company proposes to utilise the issue proceeds to finance their expansion plan that envisages setting up of an Active Pharmaceutical Ingredients (API) plant in the Pharma City.
The public offer of about 25.04 per cent of the company equity opens today. The shares will be listed on the BSE and NSE.
Last fiscal, the company closed with revenues of Rs 62 crore and profit of Rs 9 crore.
We do not recommend investors to invest in this IPO. It is bloodbath in the stock market these days and there is no point taking risk with not established companies.
Bookmark this site for all the updates on subscription, allotment and listing!
Current IPOs Subscription Status
0 comments:
Post a Comment